AzurRx BioPharma, Inc. (24)
Browse by Contract Category
Contracts
-
Settlement Agreement, by and between the Company and Fortis Advisors LLC, dated November 15, 2021
(Filed With SEC on November 16, 2021)
-
Agreement and Plan of Merger, dated September 13, 2021, by and among the Company, Alpha Merger Sub, Inc., First Wave Bio, Inc. and Fortis Advisors LLC, as shareholders...
(Filed With SEC on September 13, 2021)
-
Form of Wainwright Warrant
(Filed With SEC on July 27, 2021)
-
License Agreement, dated December 31, 2020, by and between the Company and First Wave Bio, Inc
(Filed With SEC on January 13, 2021)
-
Employment Agreement by and between AzurRx BioPharma, Inc. and Mr. Schneiderman, dated January 1, 2020
(Filed With SEC on January 6, 2020)
-
Selling Agent Agreement, by and between AzurRx BioPharma, Inc. and Alexander Capital, L.P., dated May 9, 2019
(Filed With SEC on May 14, 2019)
-
Amended and Restated Underwriting Agreement, dated July 22, 2021, between AzurRx BioPharma, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on July 27, 2021)
-
Form of Wainwright Warrant
(Filed With SEC on March 10, 2021)
-
Form of Warrant
(Filed With SEC on March 10, 2021)
-
Form of Wainwright Warrant
(Filed With SEC on January 8, 2021)
-
Employment Agreement by and between AzurRx BioPharma, Inc. and James Sapirstein, dated October 8, 2019
(Filed With SEC on October 11, 2019)
-
Form of Wainwright Warrant
(Filed With SEC on July 22, 2019)
-
Underwriting Agreement, dated July 17, 2019
(Filed With SEC on July 22, 2019)
-
Form of Selling Agent Warrant
(Filed With SEC on May 14, 2019)
-
Selling Agent Agreement, by and between AzurRx BioPharma, Inc. and Alexander Capital, L.P., dated April 1, 2019
(Filed With SEC on April 3, 2019)
-
Form of Selling Agent Warrant
(Filed With SEC on April 3, 2019)
-
Patent License Agreement, by and betweenAzurRxBioPharma, Inc. andLaboratoiresMayolySpindler SAS, dated March 27, 2019
(Filed With SEC on April 1, 2019)
-
AssetPurchaseAgreement, by and betweenAzurRxBioPharma, Inc.,AzurRxBioPharmaSAS andLaboratoiresMayolySpindler SAS, dated March 27, 2019
(Filed With SEC on April 1, 2019)
-
Senior Convertible Note A, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Registration Rights Agreement, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Warrant Amendment Agreement, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Form of Pledge Agreement, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Senior Convertible Note B, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Note Purchase Agreement, dated February 14, 2019
(Filed With SEC on February 20, 2019)
